 YAVNE, Israel, Feb. 14, 2022 GLOBE NEWSWIRE -- MediWound Ltd. Nasdaq: MDWD, a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced that management would present at two upcoming investor conferences in February. Details for each is as follows: 